2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 226.218 | 245.547 | 257.541 | 287.126 | 300.256 | 304.525 | 306.459 | 326.704 | 325.007 | 362.104 |
Total Income - EUR | 226.268 | 245.552 | 257.549 | 288.806 | 302.844 | 304.533 | 306.469 | 326.725 | 325.030 | 362.140 |
Total Expenses - EUR | 213.785 | 233.460 | 252.229 | 263.696 | 270.507 | 264.760 | 268.791 | 276.732 | 282.751 | 309.151 |
Gross Profit/Loss - EUR | 12.484 | 12.092 | 5.320 | 25.110 | 32.336 | 39.773 | 37.679 | 49.992 | 42.278 | 52.989 |
Net Profit/Loss - EUR | 9.891 | 9.591 | 3.804 | 22.029 | 29.308 | 36.728 | 34.696 | 46.735 | 39.028 | 49.367 |
Employees | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Nicofarm S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 25.449 | 23.865 | 16.459 | 15.835 | 12.660 | 12.415 | 12.180 | 11.910 | 11.947 | 11.911 |
Current Assets | 138.247 | 107.169 | 84.763 | 95.652 | 96.626 | 98.778 | 116.155 | 134.792 | 115.710 | 174.841 |
Inventories | 73.692 | 69.078 | 63.257 | 53.973 | 42.327 | 45.429 | 42.445 | 33.525 | 34.168 | 43.802 |
Receivables | 49.708 | 34.850 | 10.308 | 35.127 | 48.286 | 37.767 | 39.046 | 45.854 | 48.907 | 73.293 |
Cash | 14.847 | 3.242 | 11.199 | 6.552 | 6.014 | 15.582 | 34.664 | 55.413 | 32.635 | 57.745 |
Shareholders Funds | 108.635 | 94.836 | 61.528 | 54.933 | 61.856 | 48.707 | 60.772 | 74.423 | 58.323 | 91.219 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 55.061 | 36.199 | 39.694 | 56.554 | 47.431 | 62.486 | 67.563 | 72.279 | 69.334 | 95.533 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Nicofarm S.r.l.